TUCSON, AZ--(Marketwire - April 14, 2009) -
| Highlighted Links |
|
|
CDEX Inc. (OTCBB: CEXI), www.cdexinc.com, announces that Dr. Jefferey Burgess, MD, has joined the CDEX Team as a consultant to support work on the ID2 product line relating to detection of illegal drugs including methamphetamine. Dr. Burgess is an associate professor and the Director of the Community, Environment and Policy Division at The University of Arizona (“UA”) Mel and Enid Zuckerman College of Public Health in Tucson, Arizona. His research includes respiratory toxicology, reduction of mining-related injuries, and hazardous materials exposures including arsenic and methamphetamine laboratories. Dr. Burgess is the Principal Investigator for the CDC-funded Arizona Center for Public Health Preparedness.
Dr. Burgess has worked with many state, national and international groups on issues involving the dangers of illegal drugs, including the Arizona Attorney General’s Committee on Meth and Kids (now Drug Endangered Children) and the National Working Group on Clean-up and Remediation of Methamphetamine Laboratories. He helped develop the meth lab cleanup standards that are currently used by the State of Arizona. Dr. Burgess received an MD and a MPH from the University of Washington and an MS in toxicology and industrial hygiene from UA.
“Dr. Burgess is an internationally recognized leader in the field of methamphetamine exposure and remediation and we are delighted that he has agreed to join the CDEX Team in our work of expanding the ID2™ product line, including the Meth Scanner™,” said Tim Shriver, CDEX COO. “As the dangers of exposure to meth and meth lab precursors become more widely known, interest in the Meth Scanner from the property inspection markets, including the government health services community has risen. Dr. Burgess will assist us in improving the Meth Scanner and other ID2 products to respond to this growing problem.”
The ID2 Meth Scanner is a handheld, battery-operated device that detects trace quantities of methamphetamine while in the scan mode. Decatur Electronics (www.decaturradar.com) is the exclusive distributor of the ID2 Meth Scanner to the law enforcement market in North America and a nonexclusive worldwide distributor. For more information, please visit http://www.decaturradar.com/decatur/news_profile.php?id=55.
About CDEX
CDEX develops, manufactures and globally distributes products to the healthcare and security markets. The ValiMed™ product line provides life-saving validation of high-risk medications and returned narcotics. The ID2 ™ product line detects trace amounts of illegal drugs, such as methamphetamine. CDEX expects to advance its patented technologies to serve additional markets. To meet its plans, CDEX must strengthen its financial position as stated periodically in its SEC filings. For more information, visit www.cdexinc.com.
Non-historical statements are forward-looking, as defined in federal securities laws, and generally can be identified by words such as “expects,” “plans,” “may,” “believes,” “should,” “intends,” and similar words. These statements pose risks and uncertainties that cannot be accurately predicted or quantified and, consequently, actual results may differ materially from those expressed or implied. Such risks and uncertainties include, without limitation, the effectiveness, profitability and marketability of products, the protection of intellectual property and proprietary information, and other risks detailed periodically in filings with the SEC. There is no obligation to update any forward-looking statements.
Contact:
Malcolm Philips
Email Contact
Digg this
Bookmark with del.icio.us
Add to Newsvine
Technorati: 
